Skip to content
User banner image
User avatar
  • Rebecca Robbins

Posts

Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic...

How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for...

Robert F. Kennedy Jr. Wants to Ban Drug Ads on TV. It Wouldn’t Be Easy.

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.

Zantac’s Developer Settles Lawsuits Claiming Cancer Link

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Judge Rejects Bid to Dismiss Trump Libel Suit Against Pulitzer Board

Donald Trump sued the Pulitzer Prize Board over its 2022 statement reaffirming its decision to award a prize for coverage of the 2016 Trump campaign’s...

AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand

The shot is no longer being manufactured or supplied, and it is no longer authorized for use in Europe.

Kevin Plank, Under Armour Founder, Will Return as CEO

Kevin Plank, the sports apparel company’s controlling shareholder, will seek to reinvigorate the struggling brand.